Clear cell papillary renal cell carcinoma is an indolent and low-grade neoplasm with overexpression of cyclin-D1

Histopathology

Volumn 64, Issue 7, 2014, Pages 1032-1036

  Leroy, Xavier ^a,b   Camparo, Philippe ^c   Gnemmi, Viviane ^a,b   Aubert, Sebastien ^a,b   Flamand, Vincent ^a   Roupret, Morgan ^d   Fantoni, Jean Christophe ^a   Comperat, Eva ^d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Centre of Pathology   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Clear cell papillary carcinoma; Cyclin D1; Immunohistochemistry; Kidney

Indexed keywords

CYCLIN D1; CYTOKERATIN 7; CCND1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CHRONIC KIDNEY DISEASE; CLEAR CELL PAPILLARY RENAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; TUMOR VOLUME; CANCER GRADING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, RENAL CELL; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; TUMOR MARKERS, BIOLOGICAL;

EID: 84899944072     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12359     Document Type: Article

References (21)

1. Eble JN, Togashi K, Pisani P. Renal cell carcinoma. In Eble JN, Sauter G, Epsetin JI, Sesterhenn IA eds. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARC Press, 2004; 9-87.
2. Ross H, Martignoni G, Argani P. Renal cell carcinoma with clear cell and papillary features. Arch. Pathol. Lab. Med. 2012; 136; 391-399.
3. Tickoo SK, De Peralta-Venturina MN, Harik LR. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumour bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult adult renal neoplasia. Am. J. Surg. Pathol. 2006; 30; 141-153.
4. Aydin H, Chen L, Cheng L et al. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumours of the kidney. Am. J. Surg. Pathol. 2010; 34; 1608-1621.
5. Tickoo SK, Reuter VE. Differential diagnosis of renal tumours with papillary architecture. Adv. Anat. Pathol. 2011; 18; 120-131.
6. Goyal R, Gersbach E, Yang XJ, Rohan SM. Differential diagnosis of renal tumours with clear cytoplasm. Arch. Pathol. Lab. Med. 2013; 137; 467-480.
7. Gobbo S, Eble JN, Grignon DJ. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am. J. Surg. Pathol. 2008; 32; 1239-1245.
8. Adam J, Couturier J, Moline V, Vieillefond A, Sibony M. Clear-cell papillary renal cell carcinoma: a 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology 2011; 58; 1064-1071.
9. Williamson SR, Eble JN, Cheng L, Grignon DJ. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod. Pathol. 2013; 26; 697-708.
10. Pramick M, Ziober A, Bing Z. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics. Ann. Diagn. Pathol. 2013; 17; 437-440.
11. Hedberg Y, Ljungberg B, Roos G, Landberg G. Expression of cyclin D1, D3, E and p27 in human renal cell carcinoma analysed by tissue microarray. Br. J. Cancer 2003; 88; 1417-1423.
12. Wykoff CC, Sotiriou C, Cockman ME et al. Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. Br. J. Cancer 2004; 90; 1235-1243.
13. Calderaro J, Moroch J, Pierron G et al. SMARCB1/INI1 inactivation in renal medullary carcinoma. Histopathology 2012; 61; 428-435.
14. Rohan SM, Xiao Y, Liang Y et al. Clear cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod. Pathol. 2011; 24; 1207-1220.
15. Raval R, Lau KW, Tran MG et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol. Cell. Biol. 2005; 25; 5675-5686.
16. Bera A, Ghosh-Choudhury N, Dey N et al. NFkB- mediated cyclin D1 expression by microRNA-21 influences renal cell proliferation. Cell. Signal. 2013; 25; 575-2586.
17. Van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor 1 alpha by NF-kappa B. Biochem. J. 2008; 412; 477-484.
18. Kuhn E, De Anda J, Manoni S, Netto G, Rosai J. Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: report of 5 cases and review of the literature. Am. J. Surg. Pathol. 2006; 30; 1372-1381.
19. Shannon BA, Cohen RJ, Segal A, Baker EG, Murch AR. Clear cell renal cell carcinoma with smooth muscle stroma. Hum. Pathol. 2009; 40; 425-429.
20. Michal M, Hes O, Nemcova J. Renal angioadenomatous tumour: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009; 454; 89-99.
21. Petersson F, Grossmann P, Hora M et al. Renal cell carcinoma with areas mimicking renal angioadenomatous tumour/clear cell papillary renal cell carcinoma. Hum. Pathol. 2013; 44; 1412-1420.